BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 20062969)

  • 1. Matrix-induced autologous chondrocyte implantation versus microfracture in the treatment of cartilage defects of the knee: a 2-year randomised study.
    Basad E; Ishaque B; Bachmann G; Stürz H; Steinmeyer J
    Knee Surg Sports Traumatol Arthrosc; 2010 Apr; 18(4):519-27. PubMed ID: 20062969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Two-Year Follow-up of a Prospective Randomized Trial.
    Saris D; Price A; Widuchowski W; Bertrand-Marchand M; Caron J; Drogset JO; Emans P; Podskubka A; Tsuchida A; Kili S; Levine D; Brittberg M;
    Am J Sports Med; 2014 Jun; 42(6):1384-94. PubMed ID: 24714783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial.
    Brittberg M; Recker D; Ilgenfritz J; Saris DBF;
    Am J Sports Med; 2018 May; 46(6):1343-1351. PubMed ID: 29565642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and radiological outcomes 5 years after matrix-induced autologous chondrocyte implantation in patients with symptomatic, traumatic chondral defects.
    Marlovits S; Aldrian S; Wondrasch B; Zak L; Albrecht C; Welsch G; Trattnig S
    Am J Sports Med; 2012 Oct; 40(10):2273-80. PubMed ID: 22922521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatments of isolated articular cartilage lesions of the knee achieve similar outcomes.
    Lim HC; Bae JH; Song SH; Park YE; Kim SJ
    Clin Orthop Relat Res; 2012 Aug; 470(8):2261-7. PubMed ID: 22422593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Long-term Follow-up of Autologous Chondrocyte Implantation With Periosteum Versus Matrix-Associated Autologous Chondrocyte Implantation: A Randomized Clinical Trial.
    Barié A; Kruck P; Sorbi R; Rehnitz C; Oberle D; Walker T; Zeifang F; Moradi B
    Am J Sports Med; 2020 Jul; 48(9):2230-2241. PubMed ID: 32667270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix-induced autologous chondrocyte implantation (MACI) in the knee: clinical outcomes and challenges.
    Basad E; Wissing FR; Fehrenbach P; Rickert M; Steinmeyer J; Ishaque B
    Knee Surg Sports Traumatol Arthrosc; 2015 Dec; 23(12):3729-35. PubMed ID: 25218576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Clinical and Radiological Evaluation at 5 Years After Arthroscopic Matrix-Induced Autologous Chondrocyte Implantation.
    Ebert JR; Fallon M; Wood DJ; Janes GC
    Am J Sports Med; 2017 Jan; 45(1):59-69. PubMed ID: 27587741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes.
    Gudas R; Kalesinskas RJ; Kimtys V; Stankevicius E; Toliusis V; Bernotavicius G; Smailys A
    Arthroscopy; 2005 Sep; 21(9):1066-75. PubMed ID: 16171631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix-induced autologous chondrocyte implantation for the treatment of chondral defects of the knees in Chinese patients.
    Zhang Z; Zhong X; Ji H; Tang Z; Bai J; Yao M; Hou J; Zheng M; Wood DJ; Sun J; Zhou SF; Liu A
    Drug Des Devel Ther; 2014; 8():2439-48. PubMed ID: 25525334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between histological outcome and surgical cartilage repair technique in the knee: A meta-analysis.
    DiBartola AC; Everhart JS; Magnussen RA; Carey JL; Brophy RH; Schmitt LC; Flanigan DC
    Knee; 2016 Jun; 23(3):344-9. PubMed ID: 26898766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture.
    Saris DB; Vanlauwe J; Victor J; Almqvist KF; Verdonk R; Bellemans J; Luyten FP;
    Am J Sports Med; 2009 Nov; 37 Suppl 1():10S-19S. PubMed ID: 19846694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes.
    Gudas R; Gudaite A; Pocius A; Gudiene A; Cekanauskas E; Monastyreckiene E; Basevicius A
    Am J Sports Med; 2012 Nov; 40(11):2499-508. PubMed ID: 23024150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Techniques for Knee Cartilage Repair: An Updated Large-Scale Systematic Review and Network Meta-analysis of Randomized Controlled Trials.
    Zamborsky R; Danisovic L
    Arthroscopy; 2020 Mar; 36(3):845-858. PubMed ID: 32139062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous chondrocyte implantation using the original periosteum-cover technique versus matrix-associated autologous chondrocyte implantation: a randomized clinical trial.
    Zeifang F; Oberle D; Nierhoff C; Richter W; Moradi B; Schmitt H
    Am J Sports Med; 2010 May; 38(5):924-33. PubMed ID: 19966102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized clinical study of osteochondral autologous transplantation versus microfracture for the treatment of osteochondritis dissecans in the knee joint in children.
    Gudas R; Simonaityte R; Cekanauskas E; Tamosiūnas R
    J Pediatr Orthop; 2009; 29(7):741-8. PubMed ID: 20104156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is implantation of autologous chondrocytes superior to microfracture for articular-cartilage defects of the knee? A systematic review of 5-year follow-up data.
    Na Y; Shi Y; Liu W; Jia Y; Kong L; Zhang T; Han C; Ren Y
    Int J Surg; 2019 Aug; 68():56-62. PubMed ID: 31220632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CaReS (MACT) versus microfracture in treating symptomatic patellofemoral cartilage defects: a retrospective matched-pair analysis.
    Petri M; Broese M; Simon A; Liodakis E; Ettinger M; Guenther D; Zeichen J; Krettek C; Jagodzinski M; Haasper C
    J Orthop Sci; 2013 Jan; 18(1):38-44. PubMed ID: 23001127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of 2-Year Outcomes in Patients Undergoing Tibiofemoral or Patellofemoral Matrix-Induced Autologous Chondrocyte Implantation.
    Ebert JR; Schneider A; Fallon M; Wood DJ; Janes GC
    Am J Sports Med; 2017 Dec; 45(14):3243-3253. PubMed ID: 28910133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-term results of Autologous Matrix-Induced Chondrogenesis for treatment of focal cartilage defects in the knee.
    Gille J; Schuseil E; Wimmer J; Gellissen J; Schulz AP; Behrens P
    Knee Surg Sports Traumatol Arthrosc; 2010 Nov; 18(11):1456-64. PubMed ID: 20127072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.